Morgan Stanley’s Benitec Biopharma BNTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$402K Buy
34,322
+7,662
+29% +$89.6K ﹤0.01% 5561
2025
Q1
$347K Sell
26,660
-15,707
-37% -$204K ﹤0.01% 5497
2024
Q4
$535K Buy
42,367
+41,043
+3,100% +$518K ﹤0.01% 5391
2024
Q3
$12.2K Sell
1,324
-4,276
-76% -$39.3K ﹤0.01% 6660
2024
Q2
$39.1K Sell
5,600
-6,200
-53% -$43.3K ﹤0.01% 6245
2024
Q1
$62K Buy
11,800
+1,600
+16% +$8.4K ﹤0.01% 6136
2023
Q4
$32.9K Buy
+10,200
New +$32.9K ﹤0.01% 6495
2023
Q3
Sell
-2,271
Closed -$9.21K 7622
2023
Q2
$9.21K Sell
2,271
-405
-15% -$1.64K ﹤0.01% 6838
2023
Q1
$9.55K Sell
2,676
-19,025
-88% -$67.9K ﹤0.01% 6898
2022
Q4
$62.7K Buy
21,701
+17,231
+385% +$49.8K ﹤0.01% 6191
2022
Q3
$28K Buy
4,470
+4,129
+1,211% +$25.9K ﹤0.01% 6647
2022
Q2
$7K Buy
341
+335
+5,583% +$6.88K ﹤0.01% 7306
2022
Q1
$0 Buy
+6
New ﹤0.01% 7966
2021
Q2
Sell
-4,984
Closed -$438K 7745
2021
Q1
$438K Buy
4,984
+4,216
+549% +$371K ﹤0.01% 5227
2020
Q4
$39K Sell
768
-1,281
-63% -$65.1K ﹤0.01% 6227
2020
Q3
$219K Buy
2,049
+323
+19% +$34.5K ﹤0.01% 5065
2020
Q2
$232K Buy
1,726
+601
+53% +$80.8K ﹤0.01% 5005
2020
Q1
$113K Buy
1,125
+507
+82% +$50.9K ﹤0.01% 5140
2019
Q4
$80K Buy
618
+307
+99% +$39.7K ﹤0.01% 5720
2019
Q3
$56K Buy
311
+35
+13% +$6.3K ﹤0.01% 5675
2019
Q2
$53K Buy
276
+24
+10% +$4.61K ﹤0.01% 5577
2019
Q1
$126K Buy
252
+4
+2% +$2K ﹤0.01% 5288
2018
Q4
$95K Buy
248
+15
+6% +$5.75K ﹤0.01% 5577
2018
Q3
$141K Buy
233
+34
+17% +$20.6K ﹤0.01% 5584
2018
Q2
$101K Buy
199
+34
+21% +$17.3K ﹤0.01% 5740
2018
Q1
$134K Buy
165
+84
+104% +$68.2K ﹤0.01% 5625
2017
Q4
$61K Buy
+81
New +$61K ﹤0.01% 5771
2016
Q2
Hold
0
6512
2016
Q1
Hold
0
6571